| Alternative Dosing Strategy for Anti-HIV Drugs (NCT00059384) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-01-01 |
| Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens (NCT00052117) | Pfizer | 2003-01-01 |
| Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting (NCT00622843) | Henry M. Jackson Foundation for the Advancement of Military Medicine | 2002-12-01 |
| Safety and Efficacy of BAY 50-4798 in Patients With HIV Infection (NCT00059462) | Bayer | 2002-12-01 |
| Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN) (NCT00158405) | French National Agency for Research on AIDS and Viral Hepatitis | 2002-12-01 |
| HIV Prevention in Haitian American Adolescents (NCT00494273) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2002-12-01 |
| A Phase IIIB Study Evaluating the Effect on Serum Lipids Following a Switch to Atazanavir in HIV Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral Therapy (NCT00067782) | Bristol-Myers Squibb | 2002-12-01 |
| Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in Healthy Volunteers (NCT00050180) | National Institutes of Health Clinical Center (CC) | 2002-11-22 |
| Study of Home-Based Resistance and Strength Training in HIV-Infected Women (NCT00111332) | Massachusetts General Hospital | 2002-11-01 |
| Fuzeon (Enfuvirtide) Early Access Program for Patients With HIV-1 Infection (NCT00050856) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-11-01 |
| An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects (NCT00642291) | Gilead Sciences | 2002-11-01 |
| L-Carnitine to Treat Fatigue in AIDS Patients (NCT00079599) | National Institute of Nursing Research (NINR) | 2002-11-01 |
| A Long-term Follow-up of the HIV-NAT Cohort (NCT00411983) | The HIV Netherlands Australia Thailand Research Collaboration | 2002-11-01 |
| Physician Focused Intervention to Improve Adherence With HIV Antiretrovirals (NCT00870792) | National Institute on Drug Abuse (NIDA) | 2002-11-01 |
| Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia (NCT00270530) | Center for International Health and Development | 2002-11-01 |
| Multivitamin Dosage Regimens in the Prevention of Adverse Pregnancy Outcomes Among HIV-Positive Women (NCT00197678) | Harvard School of Public Health (HSPH) | 2002-11-01 |
| Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission (NCT00028145) | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 2002-10-01 |
| An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT� (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II) (NCT00317902) | Ortho Biotech Products, L.P. | 2002-10-01 |
| Prevention of Malaria During Pregnancy Using Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: Malawi (NCT00126906) | Centers for Disease Control and Prevention | 2002-10-01 |
| Growth Hormone to Increase Immune Function in People With HIV (NCT00071240) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-10-01 |
| Pharmacokinetics, Pharmacodynamics, And Safety Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus (NCT00643643) | ViiV Healthcare | 2002-10-01 |
| Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected Patients (NCT00052182) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-10-01 |
| Project MIX: Behavioral Intervention to Reduce Risk Among Substance-Using MSM (NCT00153361) | Gordon Mansergh | 2002-10-01 |
| Reducing HIV Risk Among Mexican Youth (NCT01084395) | University of Michigan | 2002-09-01 |
| Effects of Highly Active Anti-Retroviral Therapy on Cardiovascular Health in Infants of HIV-Infected Mothers (NCT00253682) | University of Miami | 2002-09-01 |
| Tuberculosis Prevention for HIV Infected Adults (NCT00057122) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-09-01 |
| Bupropion For Reducing High-Risk Behaviors in Depressed Men Who Have Sex With Men (MSM) (NCT00285584) | NYU Langone Health | 2002-09-01 |
| Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily Regimen (NCT00135369) | Bristol-Myers Squibb | 2002-09-01 |
| Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV (NCT00246402) | National Heart, Lung, and Blood Institute (NHLBI) | 2002-09-01 |
| Development and Evaluation of an HIV, STD, and Pregnancy Prevention Program for Middle School Students (NCT00161382) | The University of Texas Health Science Center, Houston | 2002-09-01 |
| The Effects of a Supervised Exercise Program on Self Efficacy of People Living With HIV/AIDS. (NCT00157170) | Bayside Health | 2002-09-01 |
| Effectiveness of a Community-level HIV/STD Prevention Intervention in Promoting Safer Sexual Behaviors in High-risk Populations (NCT00710060) | RTI International | 2002-09-01 |
| Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected Patients (NCT00132210) | University Hospital, Bonn | 2002-09-01 |
| Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects (NCT00043953) | Abbott | 2002-08-01 |
| To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic Abnormalities (NCT00152893) | Johane Allard | 2002-08-01 |
| Male Circumcision for HIV Prevention in Rakai, Uganda (NCT00425984) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-08-01 |
| Promoting Adherence to Anti-HIV Drug Regimens (NCT00051805) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-08-01 |
| Pre-HIV Test Counseling Intervention to Reduce HIV Infection Risk Behavior in Men Who Are Not HIV Infected (NCT00218699) | University of California, San Francisco | 2002-08-01 |
| Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children (NCT00039741) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-08-01 |
| HIV Incidence and Participation Retention in Pune, India (NCT00028119) | HIV Prevention Trials Network | 2002-08-01 |
| Screening for HIV-Associated Anal Cancer (NCT00188292) | University Health Network, Toronto | 2002-08-01 |
| IMPAACT P1058A: Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults (NCT00977756) | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 2002-08-01 |
| Daily Nevirapine to Prevent Mother to Infant Transmission of HIV (NCT00061321) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-08-01 |
| HIV Expression in Patients With Low Viral Load on Highly Active Antiretroviral Therapy (HAART) (NCT00043641) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-07-26 |
| Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects (NCT00043966) | Abbott | 2002-07-01 |
| Evaluation of Therapeutic Drug Monitoring of Protease Inhibitors on Virologic Success and Tolerance of Highly Active Antiretroviral Therapy (HAART) (NCT00122590) | French National Agency for Research on AIDS and Viral Hepatitis | 2002-07-01 |
| Lactate Metabolism Study in HIV Infected Persons (NCT00202228) | Queen's University | 2002-07-01 |
| Effect of Male Circumcision on HIV Incidence (ANRS 1265) (NCT00122525) | French National Agency for Research on AIDS and Viral Hepatitis | 2002-07-01 |
| Safety and Acceptability of Carraguard® in HIV Positive Women and Men (NCT00213005) | Population Council | 2002-06-01 |
| Liver Transplantation in Patients With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Coinfection (NCT00158535) | ANRS, Emerging Infectious Diseases | 2002-06-01 |
| A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients (NCT00046332) | GlaxoSmithKline | 2002-06-01 |
| Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen (NCT00135382) | Bristol-Myers Squibb | 2002-06-01 |
| A 14-Day Study of Racivir When Used in Combination in HIV-Infected Males (NCT00040300) | Pharmasset | 2002-06-01 |
| Study to Reduce Intravenous Exposures (STRIVE) (NCT00391482) | National Institute on Drug Abuse (NIDA) | 2002-06-01 |
| Using Drug Levels in the Blood to Guide Therapy in HIV Infected Patients Taking a Protease Inhibitor (NCT00041769) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-06-01 |
| Endothelial Dysfunction as a Risk Factor in HIV Study (NCT00039663) | National Institutes of Health Clinical Center (CC) | 2002-05-01 |
| A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor (TNF) Inhibition on HIV Disease (NCT00205231) | University of Wisconsin, Madison | 2002-05-01 |
| Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy (NCT00017719) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-05-01 |
| Multicentric Trial Comparing Three Therapeutical Strategies in Patients With Acute Primary HIV Infection (NCT00196638) | French National Agency for Research on AIDS and Viral Hepatitis | 2002-05-01 |
| Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users (NCT00164372) | Centers for Disease Control and Prevention | 2002-05-01 |
| Atazanavir for HIV Infected Individuals: An Early Access Program (NCT00046345) | Bristol-Myers Squibb | 2002-05-01 |
| Long-term Study in Patients Under Anti-retroviral Combination Therapy Switching to Viramune® (NCT02191293) | Boehringer Ingelheim | 2002-05-01 |
| Treatment of Depression With Massage in HIV (NCT00033852) | National Center for Complementary and Integrative Health (NCCIH) | 2002-04-01 |
| Video-based Intervention Study to Prevent HIV/Sexually Transmitted Diseases (STDs) Among STD Clinic Patients (NCT00137670) | Centers for Disease Control and Prevention | 2002-04-01 |
| HIV Prevention Preparedness Study in Russia, China, and India (NCT00021775) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-04-01 |
| Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-infected Patients (NCT00221650) | University Hospital, Bordeaux | 2002-04-01 |
| A Study of Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness Trials (NCT00029913) | HIV Vaccine Trials Network | 2002-04-01 |
| HORIZONS HIV Intervention (NCT00633906) | Emory University | 2002-04-01 |
| HIV Prevention for Youth With Severe Mental Illness (NCT00496691) | Rhode Island Hospital | 2002-04-01 |
| Dose Ranging Trial of Tipranavir/Ritonavir in Treatment-Experienced HIV Infected Individuals (NCT00034866) | Boehringer Ingelheim | 2002-04-01 |
| 3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study (NCT00275444) | Boehringer Ingelheim | 2002-03-29 |
| DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy (NCT00116415) | Bristol-Myers Squibb | 2002-03-01 |
| Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children (NCT00032669) | National Cancer Institute (NCI) | 2002-03-01 |
| Diagnosing Tuberculosis in HIV Infected Children in Peru (NCT00054769) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-03-01 |
| A Dose Escalation Study of Tenofovir Alafenamide in Treatment-Naive Patients (NCT00036634) | Gilead Sciences | 2002-03-01 |
| The Use of Reiki for Patients With Advanced AIDS (NCT00032721) | National Center for Complementary and Integrative Health (NCCIH) | 2002-03-01 |
| Treatment of Hepatitis C in Hemophilic Patients With HIV (NCT00055341) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-03-01 |
| Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients (NCT00028314) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-03-01 |
| Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV (NCT00056797) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-03-01 |
| Phase III PEG-Intron in HIV-infected Patients (Study P00738) (NCT00035360) | Merck Sharp & Dohme LLC | 2002-03-01 |
| Efficacy and Safety of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir in HIV-Infected Patients (NCT00122577) | French National Agency for Research on AIDS and Viral Hepatitis | 2002-03-01 |
| DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy (NCT00116116) | Bristol-Myers Squibb | 2002-03-01 |
| Screening Protocol for HIV Vaccine Studies (NCT00031304) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-02-27 |
| Consent for Use of Stored Patient Specimens for Future Testing (NCT00031408) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2002-02-13 |
| Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance (NCT00120783) | French National Agency for Research on AIDS and Viral Hepatitis | 2002-02-01 |
| Observational Study of Treated and Untreated Acute and Early HIV-1 Infection (NCT00219934) | Rockefeller University | 2002-02-01 |
| Spirituality and Will to Live in Patients With HIV/AIDS (NCT00122902) | National Center for Complementary and Integrative Health (NCCIH) | 2002-02-01 |
| Mechanisms of Lipodystrophy in HIV-Infected Pateints (NCT00457665) | University of Texas Southwestern Medical Center | 2002-02-01 |
| Neurobehavioral Model of HIV in Injection Drug Users (NCT00198861) | The City College of New York | 2002-02-01 |
| Immune Restoration by Lipoic Acid in AIDS (NCT00033176) | National Center for Complementary and Integrative Health (NCCIH) | 2002-02-01 |
| Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin (NCT00194857) | Weill Medical College of Cornell University | 2002-02-01 |
| The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin (NCT00031343) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-02-01 |
| Male Circumcision and HIV Rates in Kenya (NCT00059371) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-02-01 |
| Effects of Two Anti-HIV Drug Regimens on Quality of Life and Health Care Use Among SMART Study Participants (NCT00385632) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-01-01 |
| Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR (NCT00043888) | GlaxoSmithKline | 2002-01-01 |
| Preventing Unplanned Pregnancies in HIV Infected Zambian Couples (NCT00067522) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2002-01-01 |
| Characterization of Acute and Recent HIV-1 Infections in Zurich. (NCT00537966) | University of Zurich | 2002-01-01 |
| Trial to Evaluate Steady State Pharmacokinetic Parameters, Efficacy and Safety of Nevirapine in Antiretroviral Drug naïve Pediatric Patients (NCT00273975) | Boehringer Ingelheim | 2002-01-01 |
| Effectiveness of Raltegravir-Based Antiretroviral Therapy in HIV-HCV Coinfected Liver Transplant Recipients (NCT02995824) | Hospital Clinic of Barcelona | 2002-01-01 |
| Understanding the Increased Risk of Cardiovascular Disease in People With HIV (NCT00577681) | University of Minnesota | 2002-01-01 |